Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Not yet recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed125%
not_yet_recruiting125%
terminated125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completed

Development of a Novel Graded Prognostic Assessment (BC-LGPA) Model for Breast Cancer Leptomeningeal Metastasis

NCT07386886
not_yet_recruiting

Gastric Cancer Complicated With Bleeding

NCT06522542
recruitingnot_applicable

Effect of Oral Feeding in Infants With Pierre Robin Syndrome

NCT06267950
terminatednot_applicable

Intermittent Oro-Esophageal Tube Feeding vs. Nasogastric Tube Feeding in Infants With Pierre Robin Syndrome

NCT06178562

Clinical Trials (4)

Showing 4 of 4 trials
NCT07386886

Development of a Novel Graded Prognostic Assessment (BC-LGPA) Model for Breast Cancer Leptomeningeal Metastasis

Completed
NCT06522542

Gastric Cancer Complicated With Bleeding

Not Yet Recruiting
NCT06267950Not Applicable

Effect of Oral Feeding in Infants With Pierre Robin Syndrome

Recruiting
NCT06178562Not Applicable

Intermittent Oro-Esophageal Tube Feeding vs. Nasogastric Tube Feeding in Infants With Pierre Robin Syndrome

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4